HTDS Content Services

Exclusive

Category

Source

Publication

Byline

Location

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the eff... Read More

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate th... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy o... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mu... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab ... Read More

Clinical Trial: Evaluation of the Effectiveness and Feasibility of a Nurse-led General Advance Care Planning Booklet for Stroke Survivors at home (Japan)

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062527) titled 'Evaluation of the Effectiveness and Feasibility of a Nurse-led General Adv... Read More

Clinical Trial: Study on the utilization of sugarcane bagasse as a dietary fiber source in cold confections: Bioavailability of bagasse-containing ice cream in humans (Japan)

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062528) titled 'Study on bioavailability of sugarcane bagasse-containing ice cream in human... Read More

Clinical Trial: Comparative 90-Day Cardiovascular Outcomes After Nirmatrelvir/Ritonavir, Molnupiravir, or Ensitrelvir Initiation in Older Outpatients With COVID-19: An Active-Comparator Initiator Study (Japan)

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062526) titled 'A study comparing the 90-day risk of cardiovascular events (hospitalization... Read More

Clinical Trial: Recorded COVID-19 and Change in Measured Glycemia From Before to After Infection Among Older Adults in Japan: A Risk-Set-Matched Difference-in-Differences Study (Japan)

Posted On: 2026-08-09
Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062525) titled 'A study of whether, among older adults, recorded COVID-19 is associated wit... Read More